Catalyst Pharmaceuticals Ownership | Who Owns Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals Ownership Summary
Catalyst Pharmaceuticals is owned by 83.26% institutional investors, 6.64% insiders, and 10.10% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 16.33% of CPRX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.71% of its assets in Catalyst Pharmaceuticals shares.
CPRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Catalyst Pharmaceuticals | 83.26% | 6.64% | 10.10% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 19.43M | 16.33% | $405.40M |
| Blackrock | 18.69M | 16.01% | $289.58M |
| Vanguard group | 8.43M | 7.09% | $175.96M |
| State street | 5.80M | 4.87% | $120.97M |
| Deerfield management company, l.p. (series c) | 3.13M | 2.63% | $65.39M |
| Dimensional fund advisors lp | 3.01M | 2.53% | $62.88M |
| Pacer advisors | 2.96M | 2.49% | $61.68M |
| Goldman sachs group | 2.80M | 2.36% | $58.49M |
| Renaissance | 2.71M | 2.28% | $56.48M |
| Geode capital management | 2.67M | 2.24% | $55.64M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Tanaka capital management | 153.29K | 7.31% | $3.20M |
| Gables capital management | 417.55K | 4.20% | $8.71M |
| Jw asset management | 413.39K | 4.10% | $8.63M |
| Qsv equity investors | 84.06K | 1.69% | $1.75M |
| Knott david m jr | 210.00K | 1.58% | $4.38M |
| Resolute capital asset partners | 137.50K | 1.54% | $2.87M |
| Altium capital management lp | 255.00K | 1.51% | $5.32M |
| Deerfield management company, l.p. (series c) | 3.13M | 1.24% | $65.39M |
| Mesirow institutional investment management | 742.29K | 1.19% | $15.49M |
| Ikarian capital | 349.65K | 0.99% | $7.30M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 2.80M | 0.01% | 1.33M |
| Blackrock | 18.69M | 0.01% | 962.28K |
| Macquarie group | 682.65K | 0.02% | 682.65K |
| Ubs group | 722.86K | 0.00% | 510.01K |
| Abrdn | 484.67K | 0.02% | 484.67K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | 3.13M | 1.24% | -3.10M |
| Morgan stanley | 1.01M | 0.00% | -786.18K |
| Point72 asset management | - | - | -618.30K |
| Marshall wace, llp | 253.64K | 0.01% | -607.30K |
| Brandywine global investment management | - | - | -392.12K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Macquarie group | 682.65K | 0.02% | 682.65K | $14.25M |
| Abrdn | 484.67K | 0.02% | 484.67K | $10.11M |
| Raymond james financial | 329.98K | 0.00% | 329.98K | $6.89M |
| Clark capital management group | 207.73K | 0.03% | 207.73K | $4.34M |
| Renaissance group | 202.76K | 0.18% | 202.76K | $4.23M |
Sold Out
| Holder | Change |
|---|---|
| Mendota financial group | -12.00 |
| Aspire private capital | -20.00 |
| Financial gravity asset management | -21.00 |
| Frazier financial advisors | -82.00 |
| Northwestern mutual wealth management | -133.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 329 | 4.44% | 99,023,975 | 3.92% | 83 | 1.30% | 195 | 21.88% | 87 | -17.14% |
| Sep 30, 2024 | 313 | 14.65% | 95,228,606 | -1.82% | 80 | 1.16% | 159 | 25.20% | 104 | 18.18% |
| Jun 30, 2024 | 270 | - | 96,978,188 | 0.88% | 83 | 1.02% | 126 | -20.75% | 87 | 26.09% |
| Mar 31, 2024 | 270 | 4.25% | 96,131,186 | 13.87% | 90 | 1.44% | 159 | 39.47% | 69 | -25.81% |
| Dec 31, 2023 | 259 | 1.17% | 84,423,146 | 4.08% | 79 | 1.36% | 114 | 1.79% | 93 | 3.33% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Core S&P Small-Cap ETF | 6.93M | 5.71% | 4.19K |
| Vanguard Total Stock Mkt Idx Inv | 3.56M | 2.93% | 2.70K |
| Vanguard US Total Market Shares ETF | 3.55M | 2.91% | 3.78K |
| iShares Russell 2000 ETF | 2.97M | 2.45% | -25.74K |
| First Trust NYSE Arca Biotech ETF | 1.89M | 1.59% | - |
| T. Rowe Price Integrated US SmCapGrEq | 1.80M | 1.51% | 899.59K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.71M | 1.41% | 2.38K |
| SPDR® S&P Biotech ETF | 1.28M | 1.06% | -13.74K |
| Fidelity Small Cap Index | 1.10M | 0.91% | -20.65K |
| iShares S&P Small-Cap 600 Growth ETF | 1.02M | 0.84% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 06, 2025 | INGENITO GARY | Chief Med. & Reg. Officer | Sell | $3.90M |
| Mar 05, 2025 | INGENITO GARY | Chief Med. & Reg. Officer | Sell | $991.93K |
| Mar 03, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $1.22M |
| Mar 03, 2025 | Elsbernd Brian | Chief Compliance/Legal Officer | Sell | $225.80K |
| Mar 03, 2025 | Del Carmen Jeffrey | Chief Commercial Officer | Sell | $696.38K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q1 | - | 5 |
| 2024 Q4 | - | 14 |
| 2024 Q3 | - | 7 |
| 2024 Q2 | - | 5 |
| 2024 Q1 | - | 1 |
CPRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools